Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients

dc.contributor.author	Antón Aparicio, Luis Miguel
dc.date.accessioned	2017-06-07T07:06:59Z
dc.date.available	2017-06-07T07:06:59Z
dc.date.issued	2011
dc.identifier.issn	1465-6566
dc.identifier.uri	http://hdl.handle.net/20.500.11940/2775
dc.language.iso	eng
dc.title	Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients
dc.type	Artigo	es
dc.authorsophos	Castellano, D.
dc.authorsophos	Gonzláez-Larriba, J. L.
dc.authorsophos	Antón-Aparicio, L. M.
dc.authorsophos	Cassinello, J.
dc.authorsophos	Grande, E.
dc.authorsophos	Esteban, E.
dc.authorsophos	Sepúlveda, J.
dc.identifier.isi	295799600002
dc.identifier.pmid	21671835
dc.identifier.sophos	9042
dc.issue.number	16
dc.journal.title	EXPERT OPINION ON PHARMACOTHERAPY
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario A Coruña::Oncoloxía médica
dc.page.initial	2433
dc.page.final	2439
dc.rights.accessRights	openAccess
dc.typesophos	Artículo Original
dc.volume.number	12

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.